Generic Name and Formulations:
Acrivastine 8mg, pseudoephedrine HCl 60mg; caps.
- Early-Onset Asthma/Wheezing Associated With Later Childhood Obesity
- Dupilumab Studies Show Benefit in Chronic Rhinosinusitis With Nasal Polyps
- Gas Trapping Improved With Bronchial Thermoplasty in Severe Asthma
Indications for SEMPREX-D:
Seasonal allergic rhinitis symptoms.
1 cap every 4–6hrs; max 4 caps/day.
Severe hypertension or coronary artery disease. During or within 14 days of MAOIs.
Hypertension. Diabetes. Ischemic heart disease. Increased intraocular pressure. Hyperthyroidism. Prostatic hypertrophy. Peptic ulcer. GI obstruction. Renal impairment (CrCl ≤48mL/minute): not recommended. Elderly. Pregnancy (Cat.B). Nursing mothers.
Antihistamine + sympathomimetic.
See Contraindications. Avoid concomitant CNS depressants, OTC antihistamines and decongestants, alcohol. Potentiated by beta agonists. Antagonizes antihypertensives.
Somnolence, dry mouth, nervousness, insomnia, ephedrine-like reactions (tachycardia, palpitations, headache, dizziness, nausea).